BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9332307)

  • 1. An erythroid and megakaryocytic common precursor cell line (B1647) expressing both c-mpl and erythropoietin receptor (Epo-R) proliferates and modifies globin chain synthesis in response to megakaryocyte growth and development factor (MGDF) but not to erythropoietin (Epo).
    Bonsi L; Grossi A; Strippoli P; Tumietto F; Tonelli R; Vannucchi AM; Ronchi A; Ottolenghi S; Visconti G; Avanzi GC; Pegoraro L; Bagnara GP
    Br J Haematol; 1997 Sep; 98(3):549-59. PubMed ID: 9332307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro.
    Broudy VC; Lin NL; Kaushansky K
    Blood; 1995 Apr; 85(7):1719-26. PubMed ID: 7535585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of human interleukin-9 as a megakaryocyte potentiator in culture.
    Fujiki H; Kimura T; Minamiguchi H; Harada S; Wang J; Nakao M; Yokota S; Urata Y; Ueda Y; Yamagishi H; Sonoda Y
    Exp Hematol; 2002 Dec; 30(12):1373-80. PubMed ID: 12482498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines.
    Goncalves F; Lacout C; Féger F; Cohen-Solal K; Guichard J; Cramer E; Vainchenker W; Duménil D
    Leukemia; 1998 Sep; 12(9):1355-66. PubMed ID: 9737683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7.
    Nicolis S; Ottolenghi S; Papayannopoulou T; Baiocchi M; Migliaccio G; Adamson J; Migliaccio AR
    Exp Hematol; 1993 May; 21(5):665-70. PubMed ID: 8513868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation.
    Madoiwa S; Komatsu N; Mimuro J; Kimura K; Matsuda M; Sakata Y
    Blood; 1999 Jul; 94(2):475-82. PubMed ID: 10397715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.
    Debili N; Wendling F; Katz A; Guichard J; Breton-Gorius J; Hunt P; Vainchenker W
    Blood; 1995 Oct; 86(7):2516-25. PubMed ID: 7545460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy.
    Papayannopoulou T; Brice M; Farrer D; Kaushansky K
    Exp Hematol; 1996 Apr; 24(5):660-9. PubMed ID: 8605971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mpl ligand (MGDF) alone and in combination with stem cell factor (SCF) promotes proliferation and survival of human megakaryocyte, erythroid and granulocyte/macrophage progenitors.
    Rasko JE; O'Flaherty E; Begley CG
    Stem Cells; 1997; 15(1):33-42. PubMed ID: 9007220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin.
    Porteu F; Rouyez MC; Cocault L; Bénit L; Charon M; Picard F; Gisselbrecht S; Souyri M; Dusanter-Fourt I
    Mol Cell Biol; 1996 May; 16(5):2473-82. PubMed ID: 8628315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected and coordinated expression of Spi-1, Fli-1, and megakaryocytic genes in four Epo-dependent cell lines established from transgenic mice displaying erythroid-specific expression of a thermosensitive SV40 T antigen.
    Starck J; Mouchiroud G; Gonnet C; Mehlen A; Aubert D; Dorier A; Godet J; Morlé F
    Exp Hematol; 1999 Apr; 27(4):630-41. PubMed ID: 10210321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.
    Komatsu N; Kunitama M; Yamada M; Hagiwara T; Kato T; Miyazaki H; Eguchi M; Yamamoto M; Miura Y
    Blood; 1996 Jun; 87(11):4552-60. PubMed ID: 8639823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
    Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
    Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
    Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
    Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis.
    Choi ES; Hokom MM; Chen JL; Skrine J; Faust J; Nichol J; Hunt P
    Br J Haematol; 1996 Nov; 95(2):227-33. PubMed ID: 8904874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lyn kinase is activated following thrombopoietin stimulation of the megakaryocytic cell line B1647.
    Santini V; Scappini B; Grossi A; Gozzini A; Bonsi L; Pagliai G; Rossi Ferrini P; Bagnara GP
    Haematologica; 2002 Dec; 87(12):1242-7. PubMed ID: 12495897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3.
    Ramsfjell V; Borge OJ; Veiby OP; Cardier J; Murphy MJ; Lyman SD; Lok S; Jacobsen SE
    Blood; 1996 Dec; 88(12):4481-92. PubMed ID: 8977240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.